✦ LIBER ✦

Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study

✍ Scribed by Burroughs, Lauri; Nemecek, Eneida; Torgerson, Troy; Guthrie, Katherine A.; Talano, Julie-An; Domm, Jennifer; Shimamura, Akiko; Carpenter, Paul A.; Skoda-Smith, Suzanne; Englund, Janet A.; Baker, K. Scott; Storb, Rainer F.; Woolfrey, Ann

Book ID: 123437989
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 76 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.119

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonmyeloablative Conditioning Followed b

Nonmyeloablative Conditioning Followed by Allogeneic Marrow Grafts for Treatment of Primary Immune Deficiency Disorders: Preliminary Results of a Phase II Study

✍ L. Burroughs; T. Torgerson; B. Storer; W. Leisenring; E. Nemecek; H. Frangoul; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Phase II Prospective Multicenter Study o

Phase II Prospective Multicenter Study of Treosulfan Based Reduced intensity Conditioning in Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies From 10/10 HLA Identical Unrelated Donor

✍ M. Michallet; M. Sobh; S. Morisset; N. Tedone; J.O. Bay; J.-L. Harousseau; M. Mo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

333: Preliminary Results of Phase II Tri

333: Preliminary Results of Phase II Trial of Clofarabine with Parenteral Busulfan Followed by Allogeneic Related or Unrelated Donor Transplantation for the Treatment of Hematologic Malignancies and Diseases

✍ E.D. Agura; R.B. Berryman; J.W. Fay; L.A. Pineiro; E.A. Vance; M. Tadic-Ovcina 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Phase I-II Study of Clofarabine-Melphala

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Advanced Hematologic Malignancies: Unexpected Renal Toxicity

✍ K. van Besien; J. Kline; L. Godley; R.A. Larson; O. Odenike; E.S. Rich; W. Stock 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Allogeneic hematopoietic stem cell trans

Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: results of a prospective, multicenter study

✍ G.J. Ruiz-Arguelles; D. Gomez-Almaguer; D. Gomez-Rangel; J. Vela-Ojeda; O.G. Can 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Preliminary Results Of Phase II Trial Of

Preliminary Results Of Phase II Trial Of Clofarabine With Parenteral Busulfan (CLO/BU) Followed By Allogeneic Related Or Unrelated Donor Transplantation For The Treatment Of Hematologic Malignancies

✍ E. Agura; R.B Berryman; P. Luis; V. Estil; M. Tadic-Ovcina; R. Woelfel; J. Fay 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 57 KB